131 results
In this unique EBM Focus article, the DynaMed team answers ten frequently asked questions about coronavirus disease 2019 (COVID-19).
Seven different COVID-19 vaccines are authorized around the world. Read about availability, vaccine types, vaccine efficacy, variants and vaccination precautions from the Infectious Disease team at DynaMed®.
A scary new facet of COVID-19 in children is starting to emerge. Here’s what we know about multisystem inflammatory syndrome in children (MIS-C).
High-quality randomized trials evaluating tocilizumab continue to show only modest effects in patients with severe COVID-19. Read about the latest trial in this EBM Focus article.
Read about new open access clinical care content in EBSCO’s COVID-19 Information Portal from Jessica Bartell, MD, MS, Chief Medical Officer, Clinical Decision Support, EBSCO Clinical Decisions.
Two categories of COVID-19-directed therapy are now available to high-risk outpatients with COVID-19: monoclonal antibody therapy and antiviral agents. Hear from DynaMed® editors about outpatient therapy.
Critical care physician Dr. Constantine Manthous shares his experience with respiratory management of critically ill patients with COVID-19 pneumonia.
Ivermectin is an antiparasitic agent with in vitro activity against SARS-CoV-2 but as-of-yet unclear efficacy for treatment of COVID-19. The latest EBM Focus article discusses another trial.
COVID-19 is associated with coagulopathy and risk for thrombotic complications, but not all patients should get anticoagulation. Here is a new tool from the DynaMed Decisions® team at EBSCO that takes the guess work out of this clinical decision.
Read an update from the DynaMed Infectious Disease team about five research discoveries that have impacted clinical care of patients with COVID-19 around the world.